Michael Ramsey, founding scientist of Caliper Technologies and a research chemist at Oak Ridge National Laboratory since 1979, has accepted a research appointment to the University of North Carolina, which will begin in July. Ramsey is a corporate research fellow and leader of the Laser Spectroscopy and Microinstrumentation Group in the Chemical and Analytical Sciences Division at Oak Ridge National Laboratory. He is credited as being an inventor of the “Chemistry Lab on a Chip” technology. Ramsey holds a BS in chemistry from Bowling Green State University (1974) and a PhD in chemistry from Indiana University (1979). He told the Associated Press that he was leaving the national lab partially because it would be easier to compete for NIH grant funding at a university.
Prometheus Laboratories has appointed Bruce Neri as vice president of diagnostics R&D, and Clyde Shores as vice president of mark-eting. Neri joins Prometheus from Third Wave Technologies, where he was most recently senior vice president of R&D for its Invader technology. Prior to joining Third Wave, he was vice president of DNA probe development at Becton Dickinson. Shores served in various executive roles at companies such as Amgen and Abbott.
Interleukin Genetics has appointed Taha Keilani as medical director; Christopher Palatucci as senior director of business development and licensing; Paul Voegelin as director of operations and planning; and Gary Breton as DNA laboratory manager. Keilani comes to Interleukin from Serono, where he was medical director of clinical development and regulatory affairs. Pala-tucci comes to Interleukin from Athena Diagnostics, where he was director of business development. Voegelin comes to Interleukin from Genuity Solutions, where he was director of operations. Breton comes to the company from Genome Therapeutics, where he was project manager and senior scientist.